Federal Contract Award
Pfizer INC
$12,549,999,848
Department of Defense · March 31, 2023 · FY2023
Award ID
CONT_AWD_W58P0522C0001_9700_-NONE-_-NONE-
PIID
W58P0522C0001
Obligation Amount
$12,549,999,848
Action Date
March 31, 2023
Period of Performance
November 17, 2021 → March 31, 2023
Contract Pricing Type
FIRM FIXED PRICE
Set-Aside
NO SET ASIDE USED.
NAICS Code
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC Code
6505 — DRUGS AND BIOLOGICALS
Place of Performance
NEW YORK, NY, USA
Awarding Agency
Department of Defense
- Sub-Agency
- Department of the Army
- Office
- W6QK ACC-APG NATICK
- Funding Agency
- Department of Defense
- Funding Office
- W6DZ JPMO CBD JPMO MCS (06)
Contract Description
AWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332
See Every Contract Pfizer INC Has Won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Pfizer INC Profile →